Sign Up to like & get
recommendations!
1
Published in 2017 at "Obesity Surgery"
DOI: 10.1007/s11695-017-2770-y
Abstract: BackgroundBariatric surgery, incretin-based therapy (glucagon-like peptide-1 analogues), and sodium-glucose co-transporter 2 (SGLT2) inhibitors have antidiabetic properties in morbidly obese patients. However, their comparative efficacy in treating type 2 diabetes mellitus (T2DM) in class I obese…
read more here.
Keywords:
class obese;
treatment;
obese patients;
type diabetes ... See more keywords